# Effect of Diclofenac Sodium Versus Calcium Hydroxide as Intracanal Medication on the Intensity of Postoperative Pain, Bacterial Load Reduction and MMP-9 Levels in Patients With Necrotic Pulp.

> **NCT05582421** · EARLY_PHASE1 · UNKNOWN · sponsor: **Cairo University** · enrollment: 30 (estimated)

## Conditions studied

- Necrotic Pulp
- Apical Periodontitis

## Interventions

- **DRUG:** Diclofenac Sodium

## Key facts

- **NCT ID:** NCT05582421
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12
- **Primary completion:** 2023-10
- **Final completion:** 2024-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05582421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05582421, "Effect of Diclofenac Sodium Versus Calcium Hydroxide as Intracanal Medication on the Intensity of Postoperative Pain, Bacterial Load Reduction and MMP-9 Levels in Patients With Necrotic Pulp.". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05582421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*